SINA HONG KONG LIMITED
Patients with Advanced Solid Tumors who had Exhausted All Other Treatment Options and were PD-1 Experienced Achieved Significant Tumor Volume Reductions and Prolonged Progression Free Survival Following Treatment with NUC-3373 plus Pembrolizumab One Patient Achieved a 100% Reduction in their Target Lesion Patients with Lung Cancer who had Exhausted All
AVENTURA, Fla., Nov. 11, 2024 — Data center developer and operator Dataprana, Inc. hosted a groundbreaking ceremony for their upcoming 30 MW immersion-cooled data center at their site in La Marque, Texas on October 23, 2024. Members of the Dataprana team pose for a pre-groundbreaking photo with
This appointment reflects SimiTree’s ongoing commitment to enhancing its service offerings and delivering comprehensive support to healthcare organizations. By leveraging Lee’s expertise in both operations and growth strategy, SimiTree aims to strengthen its position as a leader in providing integrated solutions for the healthcare industry. Hamden, CT, Nov. 11, 2024
Planegg/Martinsried, November 11, 2024. Medigene AG , an oncology platform company focused on the research and development of T cell receptor -guided therapies for the treatment of cancer, presented latest updates on its End-to-End Platform technology – the UniTope and TraCR technology,
– FDA sets PDUFA Action Date of June 28, 2025 – Company Preparing for 2025 Commercial Launch – LOS ALTOS, Calif., Nov. 11, 2024 — Unicycive Therapeutics, Inc. , a clinical-stage biotechnology company developing therapies for patients with kidney disease , today announced that the
PISCATAWAY, N.J., Nov. 11, 2024 — The Waveform Architecture for Virtualized Ecosystems Consortium is pleased to announce the successful kick-off of its first working group, Working Group 1 , focused on the Hardware Abstraction and Virtualization Layer. The inaugural meeting was held on October 29, bringing together
– Data from the pivotal Phase 2b ReNeu trial demonstrate that patients with NF1-PN achieved deep responses and improvements in health-related quality of life over the course of mirdametinib treatment – – Encouraging results from Phase 1/2 study of mirdametinib in pediatric patients with low-grade glioma also to be presented
DENVER, Nov. 11, 2024 — Recently, the globally recognized cryptocurrency exchange UVKXE has introduced an innovative multi-asset wallet management feature. This new function not only enhances the efficiency of asset management for users but also underscores the ongoing commitment of UVKXE to technological development and user experience optimization.
DENVER, Nov. 11, 2024 — Recently, the globally recognized cryptocurrency exchange UVKXE has unveiled its new real-time market monitoring system. This innovative tool significantly enhances the market responsiveness of users, enabling them to swiftly adjust strategies through real-time data analysis and intelligent alert mechanisms amid the volatile cryptocurrency
Highlights Probe has commenced a 50,000-meter infill drill program at Novador aimed at resource conversion for the upcoming pre-feasibility study. 10,115 metres of infill drilling have been completed at Monique and at Courvan, with four drill rigs currently operational and plans to deploy up to 8 rigs for the winter